Blood Podcast cover image

Hodgkin lymphoma outcomes in the novel agent era, genomic safe harbors for precision T cell engineering, and a transcriptomic atlas to map imatinib resistance in CML

Blood Podcast

00:00

Introduction

The June 1st, 2023 episode of Blood Podcast is your source for innovative ideas and cutting-edge information. For patients with relapsed or refractory Hodgkin lymphoma, survival outcomes have improved after development of several novel agents. Second on today's podcast, precision engineering of therapeutic T-cells through extragenic safe harbors.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app